1.5600 0.00 (0.00%)
After hours: 4:17PM EST
|Bid||1.5300 x 800|
|Ask||1.5700 x 800|
|Day's Range||1.5396 - 1.6100|
|52 Week Range||0.9200 - 1.7900|
|Beta (5Y Monthly)||1.22|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Anyone researching Genesis Healthcare, Inc. (NYSE:GEN) might want to consider the historical volatility of the share...
On the back of its restructuring initiatives and solid membership, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
We are still in an overall bull market and many stocks that smart money investors were piling into surged through the end of November. Among them, Facebook and Microsoft ranked among the top 3 picks and these stocks gained 54% and 51% respectively. Hedge funds' top 3 stock picks returned 41.7% this year and beat […]
Tenet Healthcare's (THC) partnerships and acquisitions are likely to continue boosting its revenue base, which in turn, might perk up its share price.
Humana (HUM) collaborates with Monogram Health and Somatus to provide its Humana Medicare Advantage and Commercial members, who are renal patients, with better healthcare in select geographies.
The Zacks Analyst Blog Highlights: Cross Country Healthcare, Genesis Healthcare, Chuy's, Consulting and Huron Consulting
U.S. non-farm payroll data for November shows that job creation hasn't slowed but has shown signs of reacceleration. Here are five stocks from the best-performing sectors.
Every investor in Genesis Healthcare, Inc. (NYSE:GEN) should be aware of the most powerful shareholder groups. Large...
Genesis Healthcare (GEN) delivered earnings and revenue surprises of 380.00% and -0.56%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Genesis Healthcare's (GEN) third-quarter results are likely to reflect weak revenues, partially offset by same store facility growth and lower expenses.